-
Thanks to Ocrevus, Roche outgrows biosimilars attack to best quarter of 2018
fiercepharma
February 01, 2019
A major concern at Roche lately has been whether it can keep its head above water in the face of biosimilar challenges.
-
Bristol-Myers, Roche will top burgeoning I-O market worth $29B: analyst
fiercepharma
January 29, 2019
Bristol-Myers Squibb may be falling behind in the metastatic cancer race, and Roche is dealing with biosimilar attacks on its top-selling drugs.
-
Roche dispatches strategy executive Alexander Hardy to take Genentech helm
fiercepharma
January 28, 2019
After Roche lost its top pharma executive Dan O’Day to Gilead Sciences, the cancer giant tapped Genentech head Bill Anderson for the post, leaving a gap at the top of its crucial unit. Now, Genentech has named Roche executive Alexander Hardy to be its nex
-
Roche dispatches strategy executive Alexander Hardy to take Genentech helm
fiercepharma
January 28, 2019
After Roche lost its top pharma executive Dan O’Day to Gilead Sciences, the cancer giant tapped Genentech head Bill Anderson for the post, leaving a gap at the top of its crucial unit. Now, Genentech has named Roche executive Alexander Hardy to be its nex
-
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
fiercepharma
January 23, 2019
After two recent, huge tie-ups between Takeda and Shire and Bristol-Myers Squibb and Celgene, megamergers seem to be a biopharma trend. But Roche isn't interested in it, its chairman said.
-
Roche, PhoenixMD collaborate on diagnostic that may help identify triple-negative breast cancer patients who might benefit from RSK inhibitor PMD-026
firstwordpharma
January 17, 2019
In September, PhoenixMD announced that it raised $2.7 million to advance PMD-026 through investigational new drug (IND)-enabling studies and to develop a companion diagnostic to determine which patients have high levels of activated RSK2.
-
Merck, Roche to renew global distribution agreement
biospectrumasia
January 16, 2019
Global distribution agreement renewed under existing terms for additional five years
-
MilliporeSigma, Roche Renew Global Distribution Agreement
americanpharmaceuticalreview
January 15, 2019
MilliporeSigma and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents and Kapa Biosystems product portfolios.....
-
Roche Diabetes Care India appoints Dr Gaurav Laroia as General Manager
expressbpd
January 04, 2019
Dr Laroia joins from Roche Singapore where he was heading the Programme Management Office, APAC for Roche Pharmaceuticals
-
Roche launches 2 lab management apps under its Viewics platform
fiercebiotech
January 03, 2019
Roche has launched new two software apps that aim to optimize the financial and clinical effectiveness of diagnostics laboratories and hospitals—its first under the Viewics cloud-based analytics platform that it acquired late last year.....